Predictive Biosciences Announces Patent Issuance for Multiple Biomarker Assay

LEXINGTON, Mass.--(BUSINESS WIRE)--Predictive Biosciences, a provider of novel molecular diagnostic tests, announced that on June 7, 2011 the U.S. Patent and Trademark Office issued Patent Number 7,955,822 for “Detection of Nucleic Acids and Proteins”. The patent supports the Company’s core multiple biomarker technology for molecular testing.

MORE ON THIS TOPIC